Close

Junk DNA Could Be The Key To Understanding Neuro Ailments

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Alexion and DHL Partner for 100% Sustainable Aviation Fuel

Dublin, Alexion, AstraZeneca Rare Disease, has partnered with DHL...

Why Early Intervention Is Key To Managing Chronic Health Concerns

Proactive health management is essential for maintaining a good...

According to recent studies, there is a connection between non-coding DNA and some neurological diseases such as Alzheimer’s and motor neurone disease.

Researchers from the Universities of Sheffield and Lincoln studied how oxidative breaks in so-called junk DNA are created and repaired in order to determine whether or not doing so can one day shield humans against neurological illnesses. The revelation opens the door to ground-breaking new research into this junk DNA, which accounts for 98% of all the DNA in human cells.

This is the result of a half-decade of rigorous research by an exceptionally gifted team led by Professor Sherif El-Khamisy at the University of Sheffield, according to lead author and senior lecturer in cell biology at the School of Life and Environmental Sciences at the University of Lincoln, Dr. Swagat Ray.

Oxidative stress is a natural byproduct of cellular metabolism and is influenced by a variety of variables, including the environment, diet, and lifestyle. Long-term oxidative stress can harm the body’s cells, proteins, and DNA irreparably, speeding up ageing and promoting the growth of brain illnesses like dementia, the researcher continued.

Neurological disorders, including motor neurone disease and Alzheimer’s, which are brought on by the progressive death of brain cells called neurons, affect up to a billion individuals worldwide.

The results of this study can now open the door for further investigation that may result in the earlier detection, postponement, or even cure of numerous neurological illnesses.

Latest stories

Related stories

Alexion and DHL Partner for 100% Sustainable Aviation Fuel

Dublin, Alexion, AstraZeneca Rare Disease, has partnered with DHL...

Why Early Intervention Is Key To Managing Chronic Health Concerns

Proactive health management is essential for maintaining a good...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back